1548 (1548) News
Follow 1548 (1548) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Genscript Biotech to place 77.1 million shares
Genscript Biotech Corp plans to place 77.1 million shares at HK$30.50 per share on the HKEX.
EQUITY | Sep 11, 2026, 01:29 AM UTC
M
Genscript Biotech to raise HK$2.35B via private placement
Genscript Biotech plans to raise HK$2.35B by placing 77.12M shares at HK$30.50 each, a 4.7% discount to the last quoted price of HK$32.00 per share.
EQUITY | Sep 11, 2026, 12:45 AM UTC
L
Two Chinese pharma firms seek Hong Kong listings, incl. Salubris
Shenzhen Salubris Pharmaceuticals has applied for a Hong Kong listing, per an exchange filing. The sector is cited as the next wave of offerings in the city; no listing timeline details were provided.
EQUITY | Sep 04, 2026, 01:44 AM UTC
M
Genscript Biotech proposes spin-off and separate listing of Probio Technology
Genscript Biotech Corp proposes a spin-off and separate listing of Probio Technology.
EQUITY | Sep 04, 2026, 01:32 AM UTC
L
Genscript Biotech to keep controlling interest in ProBio after listing
Genscript Biotech says it will keep a controlling interest in ProBio after listing.
EQUITY | Sep 04, 2026, 12:30 AM UTC
L
Genscript ProBio spin-off details not yet finalized
Genscript says details of its ProBio spin-off are yet to be finalized.
EQUITY | Sep 04, 2026, 12:30 AM UTC
M
Genscript Biotech plans spin-off and Hong Kong listing of Probio
Genscript Biotech plans a spin-off and a Hong Kong listing of its non-wholly-owned subsidiary Probio Technology.
EQUITY | Sep 04, 2026, 12:28 AM UTC